The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Therapeutic value of para-aortic lymph node dissection in gastric cancer with extensive lymph node metastasis: Integrated analysis of three phase II trials (JCOG2212A).
 
Takeyuki Wada
No Relationships to Disclose
 
Masayuki Yokoyama
No Relationships to Disclose
 
Seiji Ito
Honoraria - Taiho Pharmaceutical
Research Funding - AstraZeneca (Inst); Merck Sharp & Dohme (Inst); Ono Pharmaceutical (Inst)
 
Tadayoshi Hashimoto
Honoraria - Cytogen; Takata Pharmaceutical
 
Kota Kawabata
No Relationships to Disclose
 
Kazuhisa Ehara
No Relationships to Disclose
 
Takashi Nomura
No Relationships to Disclose
 
Masaki Aizawa
Honoraria - Bristol Myers Squibb Foundation; Johnson & Johnson/MedTech; Medtronic; MSD; Ono Pharmaceutical; Taiho Pharmaceutical
 
Ryohei Kawabata
No Relationships to Disclose
 
Daisuke Takahari
Honoraria - Astellas Pharma; Bristol-Myers Squibb Japan; Daiichi Sankyo/UCB Japan; Lilly Japan; Ono Pharmaceutical; Taiho Pharmaceutical
Research Funding - Ono Pharmaceutical (Inst); Taiho Pharmaceutical (Inst)
 
Mitsuru Sasako
Honoraria - Daiichi Sankyo; Ono Pharmaceutical
 
Akira Tsuburaya
No Relationships to Disclose
 
Takeshi Sano
Speakers' Bureau - Ono Pharmaceutical
 
Masanori Terashima
Honoraria - Bristol-Myers Squibb; Daiichi Sankyo; Intuitive Surgical; Johnson & Johnson; Lilly; Olympus; Ono Pharmaceutical; Taiho Pharmaceutical; Yakult Honsha
 
Narikazu Boku
Honoraria - Bristol-Myers Squibb Japan; Daiichi-Sankyo; Lilly; Ono Pharmaceutical; Taiho Pharmaceutical
 
Yukinori Kurokawa
Honoraria - Astellas Pharma; Daiichi Sankyo; Johnson & Johnson; Lilly; MC Medical; Medtronic; MSD; Nippon Kayaku; Ono Pharmaceutical; Stryker; Taiho Pharmaceutical; Yakult Honsha
Consulting or Advisory Role - Astellas Pharma; Taiho Pharmaceutical
Research Funding - AstraZeneca (Inst); MSD Oncology (Inst); Ono Pharmaceutical (Inst); Taiho Pharmaceutical (Inst); Yakult Honsha (Inst)
 
Takaki Yoshikawa
Honoraria - Astellas Pharma; AstraZeneca; BMS; Chugai Pharma; Daiichi Sankyo; Intuitive Surgical; Johnson & Johnson/Janssen; Medtronic; Olympus; Ono Pharmaceutical; Taiho Pharmaceutical
Consulting or Advisory Role - MSD Oncology; TERUMO
Research Funding - Lilly